by Jordana Choucair | Dec 20, 2022 | Life Sciences
CVS and Walgreens are limiting purchases of children’s pain-relief medicine amid rising cases of flu, COVID-19, and RSV. “Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint...
by Jordana Choucair | Dec 20, 2022 | Payers
The U.S. Department Health and Human Services (HHS) Office of the Inspector General (OIG) released a report revealing that Medicare Part B spending on lab tests surged last year to $9.3 billion. The 17 percent increase was driven by higher volumes of COVID-19 tests...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
Health systems and pharmacies are running out of antibiotics, antivirals, and pediatric cold and flu medications as the worst flu season in more than a decade collides with increased RSV and COVID-19 cases. The situation started when antibiotics manufacturers like...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
The Food and Drug Administration (FDA) declared a shortage of Eli Lilly & Co.’s diabetes drug Mounjaro. The FDA informed pharmacies that they should expect full shipment delays for 5-milligram doses. However, the University of Utah drug information service,...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
The FDA Vaccines and Related Biological Products Advisory Committee will hold a key meeting on January 26 to discuss the state of the pandemic and whether COVID-19 vaccines need to be modified again to better limit the fast-changing virus. The FDA is looking to get...
by Jordana Choucair | Dec 19, 2022 | Mental Health
A Wall Street Journal article examines how the surge in digital mental health treatment instigated a decline in the quality of care. According to the article, many of the new digital mental health companies used “classic Silicon Valley tactics” such as using...
Recent Comments